HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to tame throat cancer with fewer side effects
Disease control Not yet recruitingThis study tests whether a new drug (ATRN-119) combined with a single, precise dose of radiation can safely treat early-stage HPV-positive throat cancer. About 35 adults will take the drug for 10 days and receive one radiation treatment, then have standard surgery. Researchers ho…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: John Lukens • Aim: Disease control
Last updated May 26, 2026 11:49 UTC
-
Blood test guides throat cancer therapy, aims to boost survival
Disease control Not yet recruitingThis study tests whether using a blood test that detects HPV DNA can help doctors choose the right level of treatment for people with HPV-positive throat cancer. About 116 participants with early-stage cancer will receive therapy tailored to their risk, based on blood results and…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 11:47 UTC
-
Could less radiation be better for HPV throat cancer? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether lowering radiation doses to certain areas can reduce side effects for people with HPV-related throat cancer, which typically has good outcomes. About 132 participants will receive either reduced radiation to low-risk lymph nodes, a lower dose to the tumor…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC